Beckman Coulter Diagnostics earns CE mark for new assay delivering bacterial vs viral infection results in approximately 20 minutes
Sănătate
From Beckman Coulter Diagnostics Apr 13 2026 Beckman Coulter Diagnostics, a Danaher company and global leader in clinical diagnostics, today announced it has received CE 2797 mark under IVDR for the Access MeMed BV assay, enabling broad availability of a high-throughput host‑response test that helps clinicians differentiate between bacterial and viral infections in approximately 20 minutes. Image Credit: Beckman Coulter Diagnostics Validated for use across Beckman Coulter’s installed base of
astăzi